title: Biotechnology company's shares dive 67% after drug failure.
authors.forename: R
authors.initials: R
authors.lastname: Dobson
mesh_terms: D001709:Biotechnology / Q000191:economics*; D003132:Commerce; D004345:Drug Industry / Q000191:economics*; D004791:Enzyme Inhibitors / Q000191:economics; D006801:Humans; D006877:Hydroxamic Acids / Q000191:economics; D017211:Treatment Failure
chemical_list: D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C100342:marimastat